您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览120

To review the optimal management of type 2 diabetes mellitus (T2DM) in the older adult.A PubMed search was completed to identify publications in the English language from 1947 to 2013 using combinations of the search terms: geriatrics, aged, diabetes mellitus, and type 2 diabetes mellitus. References of articles were also reviewed for inclusion if not identified in the PubMed search.Original studies, clinical reviews, and guidelines were identified and evaluated for clinical relevance.Although the number of older adults with T2DM is growing, evidence for the treatment of T2DM in this population is lacking. Barriers such as polypharmacy, comorbid conditions, economic limitations, cognitive impairment, and increased risk of hypoglycemia may limit optimal glycemic control in older adults. Several organizations provide recommendations for glycemic targets and recommend using standard glycemic goals in most healthy older adults. However, less stringent goals are necessary in certain older populations such as those patients with limited life expectancy and severe hypoglycemia. In general, glycemic goals should be individualized in older patients. Age-related pharmacokinetic and pharmacodynamic changes, comorbid conditions, adverse drug reactions, ease of medication administration, and cost of medications necessitate the need to individualize pharmacologic therapy.Glycemic targets and medication use for T2DM should be individualized in older adults.

作者:Angela M, Thompson;Sunny A, Linnebur;Joseph P, Vande Griend;Joseph J, Saseen

来源:The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 2014 年 29卷 2期

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:120
作者:
Angela M, Thompson;Sunny A, Linnebur;Joseph P, Vande Griend;Joseph J, Saseen
来源:
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 2014 年 29卷 2期
标签:
A1c = Glycated hemoglobin AACE = American Association of Clinical Endocrinologists ADA = American Diabetes Association AUC = Area under the curve Aged CV = cardiovascular Clcr = Creatinine clearance Cmax = Maximum concentration DM = Diabetes mellitus DPP-IV = Dipeptidyl peptidase Diabetes mellitus EASD = European Association for the Study of Diabetes FDA = Food and Drug Administration Food and Drug Administration GFR = Glomerular filtration rate GI = Gastrointestinal GLP = Glucagon-like peptide Geriatrics Hypoglycemia Insulin NPH = Neutral protamine Hagedorn NYHA = New York Heart Association SCr = Serum creatinine T2DM = Type 2 diabetes mellitus TZD = Thiazolidinedione Thiazolidinediones Type 2 diabetes mellitus UKPDS = United Kingdom Prospective DM Study m = Meter min = Minute
To review the optimal management of type 2 diabetes mellitus (T2DM) in the older adult.A PubMed search was completed to identify publications in the English language from 1947 to 2013 using combinations of the search terms: geriatrics, aged, diabetes mellitus, and type 2 diabetes mellitus. References of articles were also reviewed for inclusion if not identified in the PubMed search.Original studies, clinical reviews, and guidelines were identified and evaluated for clinical relevance.Although the number of older adults with T2DM is growing, evidence for the treatment of T2DM in this population is lacking. Barriers such as polypharmacy, comorbid conditions, economic limitations, cognitive impairment, and increased risk of hypoglycemia may limit optimal glycemic control in older adults. Several organizations provide recommendations for glycemic targets and recommend using standard glycemic goals in most healthy older adults. However, less stringent goals are necessary in certain older populations such as those patients with limited life expectancy and severe hypoglycemia. In general, glycemic goals should be individualized in older patients. Age-related pharmacokinetic and pharmacodynamic changes, comorbid conditions, adverse drug reactions, ease of medication administration, and cost of medications necessitate the need to individualize pharmacologic therapy.Glycemic targets and medication use for T2DM should be individualized in older adults.